# Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy

> **NCT04191928** · PHASE1 · COMPLETED · sponsor: **Thomas Jefferson University** · enrollment: 4 (actual)

## Conditions studied

- Pancreas Cancer
- DVT
- Pulmonary Embolism

## Interventions

- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT04191928
- **Lead sponsor:** Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-03
- **Primary completion:** 2020-07-25
- **Final completion:** 2021-09-01
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2021-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04191928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04191928, "Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04191928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*